Aptus Pharma Ltd vs Curis Lifesciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 12, 2026

Key Highlights

The Latest Trading Price of Aptus Pharma Ltd is ₹ 216.1 as of 12 Jun 10:58 . The P/E Ratio of Aptus Pharma Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Curis Lifesciences Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of Aptus Pharma Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Curis Lifesciences Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The Revenue of Aptus Pharma Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Curis Lifesciences Ltd is ₹ 9.12 crore as of Jun '24 . The EBITDA of Aptus Pharma Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Curis Lifesciences Ltd is ₹ 2.73 crore as of Jun '24 . The Net Profit of Aptus Pharma Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Curis Lifesciences Ltd is ₹ 1.2 crore as of Jun '24 . The Dividend Payout of Aptus Pharma Ltd changed from 0 % on March 2022 to 0 % on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Dividend Payout of Curis Lifesciences Ltd changed from 0 % on March 2022 to 0 % on March 2025 . This represents a CAGR of 0.0% over 4 years .

About Aptus Pharma Ltd

Aptus Pharma Limited was originally incorporated as 'Aptus Pharma Private Limited', as a private limited company with the Registrar of Companies, Gujarat, pursuant to a Certificate of Incorporation dated August 12, 2010.
Subsequently, Company was converted into a public limited retaining the name as 'Aptus Pharma Limited' and a fresh certificate of incorporation dated December 12, 2024 was issued by the Registrar of Companies, Central Processing Centre. Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations.
While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model with 7 units. under various arrangements.
It provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products.

About Curis Lifesciences Ltd

Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of 'M/s Loreto Pharmaceutacals', pursuant to a Deed of Partnership dated 2 June, 2010.
Thereafter ' M/s Loreto Pharmaceutacals' was converted from Partnership Firm to a Private Limited Company as 'Curis Lifesciences Private Limited' and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad.
Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed from 'Curis Lifesciences Private Limited' to 'Curis Lifesciences Limited' vide certified incorporated upon the conversion dated August 9, 2024, issued by the Central Processing Centre, Manesar. Company's business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic.

FAQs for the comparison of Aptus Pharma Ltd and Curis Lifesciences Ltd

Which company has a larger market capitalization, Aptus Pharma Ltd or Curis Lifesciences Ltd?

Market cap of Aptus Pharma Ltd is 378 Cr while Market cap of Curis Lifesciences Ltd is 88 Cr

What are the key factors driving the stock performance of Aptus Pharma Ltd and Curis Lifesciences Ltd?

The stock performance of Aptus Pharma Ltd and Curis Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aptus Pharma Ltd and Curis Lifesciences Ltd?

As of June 12, 2026, the Aptus Pharma Ltd stock price is INR ₹220.5. On the other hand, Curis Lifesciences Ltd stock price is INR ₹109.45.

How do dividend payouts of Aptus Pharma Ltd and Curis Lifesciences Ltd compare?

To compare the dividend payouts of Aptus Pharma Ltd and Curis Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.